TULIPIA Trial Using BIM23A760 dose Levels In Patients In Acromegaly

WIPO WIPO 2010

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark TULIPIA Trial Using BIM23A760 dose Levels In Patients In Acromegaly was filed as Word mark on 10/14/2010 at the World Intellectual Property Organization.

Trademark Details Last update: October 28, 2021

Trademark form Word mark
File reference 1056151
Countries Russia Ukraine United States of America (USA)
Base trademark EU No. 009310889, July 26, 2010
Application date October 14, 2010
Expiration date October 14, 2020

Trademark owner

65 quai Georges Gorse
F-92100 BOULOGNE BILLANCOURT
FR

Trademark representatives

65 quai Georges Gorse F-92100 BOULOGNE BILLANCOURT FR

goods and services

42 Conducting medical, pharmaceutical and scientific study programs, conducting clinical studies and analyses, scientific, medical and pharmaceutical research

Trademark history

Date Document number Area Entry
October 25, 2021 2021/43 Gaz Deletion
August 10, 2012 2012/33 Gaz US Rejection
April 23, 2012 2012/20 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 14, 2011 2011/42 Gaz UA Rejection
September 22, 2011 2011/39 Gaz RU Rejection
January 10, 2011 2011/2 Gaz US Rejection
October 14, 2010 2010/45 Gaz EM Registration

ID: 141056151